T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy

A chemosensitivity test to individualize intravesical treatment for non-muscle-invasive bladder cancer

(2009) Paola Gazzaniga et al.   BJU INTERNATIONAL

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

(2009) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

What is the Optimal Treatment Strategy for T1 Bladder Tumors?

(2009) Marko Babjuk   EUROPEAN UROLOGY

An Updated Critical Analysis of the Treatment Strategy for Newly Diagnosed High-grade T1 (Previously T1G3) Bladder Cancer

(2009) Girish S. Kulkarni et al.   EUROPEAN UROLOGY

Oncological Followup After Radical Cystectomy for Bladder Cancer—Is There Any Benefit?

(2009) Bjoern G. Volkmer et al.   JOURNAL OF UROLOGY

Quantification of the survival benefit of early versus deferred cystectomy in high-risk non-muscle invasive bladder cancer (T1 G3)

(2009) Richard E. Hautmann et al.   WORLD JOURNAL OF UROLOGY